Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GSK3787
Cat. No.:
0225LY-0817
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
GSK3787 acts as an irreversible and specific inhibitor of PPAR-delta, with a pIC50 of 6.6.
Synonym:
188591-46-0; 4-Chloro-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]benzamide; 4-chloro-N-[2-[5-(trifluoromethyl)pyridin-2-yl]sulfonylethyl]benzamide; CHEMBL598608; MFCD00099612; DD8MJ95LTV; 4-chloro-N-(2-((5-(trifluoromethyl)pyridin-2-yl)sulfonyl)ethyl)benzamide; Benzamide, 4-chloro-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]-; 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide; 4-Chloranyl-N-(2-(5-(trifluoromethyl)pyridin-2-yl)sulfonylethyl)benzamide; Maybridge3_000547; 4-chloro-N-(2-(5-(trifluoromethyl)pyridin-2-ylsulfonyl)ethyl)benzamide; 4-chloro-N-{2-[5-(trifluoromethyl)pyridin-2-ylsulfonyl]ethyl}benzamide
CAS No.:
188591-46-0
Compound CID:
2800647
Formula:
C15H12ClF3N2O3S
Formula Weight:
392.78
Specification
Targets&IC50:
PPARδ: 6.6(pIC50)
Relative Density:
1.448 g/cm3 at 20°C
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
GSK3787 can be used in biochemical research to investigate the irreversible and selective antagonism of the PPAR delta receptor.
Library Information
Target:
PPAR
Receptor:
PPARδ
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-11
Plate Location:
e6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
125 mg/mL; 318.24 mM
ALogP:
3.207
HBA_Count:
4
HBD_Count:
1
Rotatable Bond:
6
